Self-reported study evaluates impact of buprenorphine on deep and depression in individuals in medication assisted-treatment with buprenorphine
Self-reported Sleep Improvement in Buprenorphine MAT (Medication-assisted Treatment) Population
School, Department, or Center
School of Medicine, Department of Behavioral Medicine & Psychiatry
Wanhong Zheng, MD, MSc, MA
The purpose of this study is to evaluate the impact buprenorphine has on sleep and depression in individuals in medication assisted-treatment with buprenorphine. Surveys were administered at baseline, 30, 60, and 90 days to evaluate both self-reported sleep and depression. This study found that buprenorphine/naloxone maintained opioid use disorder patients in early recovery reported improvement in both sleep and depression during the first 90 days treatment. A manuscript has been submitted for publication detailing these results.
Monongalia and surrounding counties« Back to Research Initiatives